Atrial septal defects (ASDs) represent the most common congenital heart defect diagnosed
in adulthood. Although considered a simple defect, challenges in optimal diagnostic and …

The field of congenital interventional cardiology has experienced tremendous growth in
recent years. Beginning with the development of early devices for transcatheter closure of …

Device closure has become the preferred procedure for treating oval fossa defects in the last
two decades. More recently, transcatheter sinus venosus defect (SVD) closure has emerged …

Objectives To evaluate bare-metal Optimus and polytetrafluoroethylene (PTFE)-covered
Optimus-CVS balloon-expandable, cobalt–chromium, hybrid cell–designed stents in …

Superior sinus venosus defect is characterized by varying degrees of override of the atrial
septum by the superior vena cava and anomalous right upper pulmonary vein (RUPV) …

Transcatheter correction of superior sinus venosus defects using covered stent is
increasingly reported in the literature and provides an alternative option to surgery in …

Background Transcatheter correction of sinus venosus defects (SVDs) using balloon-
mounted covered stents provides an attractive surgical alternative. Surgery may be …

Transcatheter device intervention is now offered as first line therapy for many congenital
heart defects (CHD) which were traditionally treated with cardiac surgery. While off-label use …

Transcatheter sinus venosus defect closure uses a long covered stent of appropriate length
and diameter across the cavoatrial junction after balloon interrogation. The fabric in the …

Covered stent correction of a superior sinus venosus atrial septal defect is increasingly
performed as an alternative to surgical repair. While sinus node dysfunction requiring …